# Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions

Study · id `cardio:ct-nct01750775` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01750775](<https://clinicaltrials.gov/study/NCT01750775>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01750775

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.

## Technical summary

Registry record NCT01750775. Randomized; triple masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 330 participants (planned count; ClinicalTrials.gov record NCT01750775, source copy `cardio:ctgov-nct01750775-2012-12-17`, retrieved 2026-10-26)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01750775, source copy `cardio:ctgov-nct01750775-2012-12-17`, retrieved 2026-10-26)
- Primary completion: 2013-09 (anticipated) (ClinicalTrials.gov record NCT01750775, source copy `cardio:ctgov-nct01750775-2012-12-17`, retrieved 2026-10-26)
- Completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01750775, source copy `cardio:ctgov-nct01750775-2012-12-17`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01750775, source copy `cardio:ctgov-nct01750775-2012-12-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01750775-2012-12-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions
- Acronym: SS-SBVPT
- Condition: Premature Ventricular Contraction
- Intervention (Drug): Shensong Yangxin capsule
- Intervention (Drug): placebo Capsule
- Lead sponsor: kejiang Cao
- Lead sponsor class: OTHER
- Collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator class: OTHER
- Collaborator: Third Military Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Premature heartbeats (`cardio:premature-heartbeats`)
- Registry lists this organization as a collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital (`cardio:org-chinese-academy-of-medical-sciences-fuwai-hospital`)
- Registry lists this organization as a collaborator: Third Military Medical University (`cardio:org-third-military-medical-university`)

## Provenance

Content hash: 95b5e4ffdf83fcf71ef176b6af295438be2135de7d548afb111b0226c439e5b2
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
